Organisation paid for research Program year 2023 Source: CMS Open Payments

Advanced Pulmonary Research

Neither a doctor nor a teaching hospital

Research payments

$200,003

12 payments

Through program year 2023, Advanced Pulmonary Research is reported as receiving $200,003 in research payments, across 12 payments.

By program year

2 rows
Year Kind Amount Payments
2023 Research $151,434 3
2022 Research $48,569 9

Breakdown

Who paid Research payments · program years 2022–2023
  1. Boehringer Ingelheim Pharmaceuticals, Inc. $163,044 4 payments
  2. Hoffmann-La Roche Limited $36,959 8 payments
Studies the money was for Research payments · program years 2022–2023
  1. PDE4 Phase III trial in PF ILD $140,313 1 payment
  2. PH Iib of Astegolimab in COPD $36,959 8 payments
  3. PDE4 Phase III trial in IPF patients $14,731 2 payments
  4. Low Intervention Cough Monitoring Study in PPF IPF $8,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record